HOME
작성자 : admin작성일 : 2018-07-04 17:19 첨부파일 :2018) J Clin Phar Thera- Combination of apatinib and continuous nutritional support for a gastric cancer patient with brain met

Combination of apatinib and continuous nutritional support for a gastric cancer patient with brain metastasis prolongs survival

Abstract
WHAT IS KNOWN AND OBJECTIVES:
Gastric cancer is the most common gastrointestinal malignant tumour in China, which rarely metastasizes into the central nervous system. However, brain metastasis leads to increased risk of death.

CASE SUMMARY:
Here, we report a case of brain metastasis from gastric cancer, which was treated with apatinib and continual nutritional support, with a survival time of 2 years.

WHAT IS NEW AND CONCLUSION:
The combination of apatinib and continual nutritional support may be an option for the treatment of brain metastasis from gastric cancer. A prospective study should be performed to confirm this.